0001209191-23-027361.txt : 20230504 0001209191-23-027361.hdr.sgml : 20230504 20230504163807 ACCESSION NUMBER: 0001209191-23-027361 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230412 FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Marlan D CENTRAL INDEX KEY: 0001820187 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 23889471 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD STREET 2: SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-961-1900 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0407 4/A 2023-04-12 2023-04-14 0 0000025743 TherapeuticsMD, Inc. TXMD 0001820187 Walker Marlan D 951 YAMATO ROAD SUITE 220 BOCA RATON FL 33431 0 1 0 0 Chief Executive Officer 0 Common Stock 2023-04-26 4 M 0 1010 0.00 A 14041 D Common Stock 2023-04-26 4 M 0 1734 0.00 A 12307 D Common Stock 2023-04-26 4 S 0 692 3.6381 D 11615 D Restricted Stock Units 0.00 2023-04-26 4 M 0 1010 0.00 D Common Stock 1010 0 D Restricted Stock Units 0.00 2023-04-26 4 M 0 1734 0.00 D Common Stock 1734 3466 D The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023. The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations. Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023. Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. /s/ Marlan D. Walker 2023-05-04